Angiotensin II Receptor Blocker as an Inverse Agonist: A Current Perspective
Journal:
Current Hypertension Reviews
Volume:
1
Page:
115-121
Author(s):
Shin-ichiro Miura, Masahiro Fujino and Keijiro Saku
Mediterranean Diet and Hypertension; From the Clinical and Epidemiologic Evidences to Prevention
Journal:
Current Hypertension Reviews
Volume:
1
Page:
123-128
Author(s):
Peter Kokkinos, Evangelos Polychronopoulos and Demosthenes B. Panagiotakos
Treatment of Tachycardia in Hypertension: Where Do We Stand Now?
Journal:
Current Hypertension Reviews
Volume:
1
Page:
129-140
Author(s):
Paolo Palatini
Improving Antihypertensive Agent Selection to Promote Nephroprotection
Journal:
Current Hypertension Reviews
Volume:
1
Page:
141-157
Author(s):
John B. Standridge
The Role of Chymase in Vascular Remodeling and Tissue Fibrosis
Journal:
Current Hypertension Reviews
Volume:
1
Page:
159-168
Author(s):
Shinji Takai, Denan Jin, Michiko Muramatsu and Mizuo Miyazaki
Adrenomedullin in Hypertension
Journal:
Current Hypertension Reviews
Volume:
1
Page:
169-181
Author(s):
Toshio Nishikimi and Hiroaki Matsuoka
Role of Salt and Potassium in Hypertension and the Associated Organ Damages
Journal:
Current Hypertension Reviews
Volume:
1
Page:
183-187
Author(s):
Katsuyuki Ando and Toshiro Fujita
GABAA Receptor Channel Pharmacology
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1867-1885
Author(s):
Graham A.R. Johnston
Molecular Pharmacology of Non-L-type Calcium Channels
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1887-1898
Author(s):
Clinton J. Doering and Gerald W. Zamponi
Novel Targets for Cardiac Antiarrhythmic Drug Development
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1959-1974
Author(s):
John Christian Hesketh, Daniel Herrera, Stephen Zicha and Stanley Nattel